Name: MRK Rallies on Drug Approval & MRNA Researches Flu
Uploaded: 2024-03-27T16:52:24.651-05:00
Duration: 3 min 39 s
Description: Merck (MRK) rallies after FDA drug approval. Kevin Green discusses this as Merck receives FDA approval for drug Winrevair to treat pulmonary arterial hypertension. Green also goes over how Moderna (MRNA) is trading higher after a $750M investment in flu research. Tune in to find out more about the stock market today.

Don’t miss the go-to resource for pre-market action from the floor of the New York Stock Exchange. Join Diane King Hall for breaking economic news, expert analysis, technical insights, and real-time trading strategies.

Morning Movers

Kick off the trading day tying big macro concepts together with stock-specific analysis and trading strategies. This program cuts through the noise and political bias, while helping viewers understand the economy's relationship with markets through numbers, logic and in-depth interviews with fund managers, ETF providers and options traders.&nbsp;

Morning Trade Live

After the dust settles from the opening bell,&nbsp;Trading 360&nbsp;with Nicole Petallides&nbsp;features Wall Street’s best traders, analysts and technicians to break down sectors and stocks moving markets. Trading 360&nbsp;with Nicole Petallides focuses on disruptive companies and new technologies driving market&nbsp;headlines while providing investors a 360 degree actionable approach to trading.

Trading 360

Hosts Tom White and Kevin Hincks break down the market; providing in-depth insights for Intermediate to Advanced Traders on how to interpret current market activity. Technical market specialists, analysts and outside guests join the program, giving their take on different markets, sectors, and various products.

Fast Market

The future of trading is here on Next Gen Investing. Alex Coffey and Jenny Horne take viewers through the markets from a unique perspective to help new investors pursue their financial goals. Next Gen Investing will explore various trading strategies while highlighting trending names and under the radar stocks in the market, while walking investors through real-time example trades.

Next Gen Investing

The Watch List with Nicole Petallides offers investors a midday look at the most relevant stocks, sectors and commodities. Petallides hosts a panel of experts ranging from industry-leading CEOs, analysts and Wall Street influencers to discuss pressing topics moving the market in real-time. The Watch List provides viewers with a midpoint status update for the end of the trading day and beyond.

The Watch List

Wrap up your trading day with a live recap of the day's top stories and market movers, then look ahead to tomorrow's expectations and upcoming events.

Market On Close

Market Overtime takes a break from the day-to-day news cycle and explores global financial trends with veteran investors and leading market minds. The show is a conversation looking at what is driving headlines globally, and what these trends mean for markets, the economy, and your financial future. What are the stories that will impact your portfolio for the next year, next decade and beyond? Tune in to Market Overtime to get a new perspective on investing.

Market Overtime

Ever wonder what&nbsp;really&nbsp;makes a trader tick? Watch as a renowned neuroscientist takes you inside the minds of some of the most brilliant traders so you can discover ways you might apply their thinking to your own strategies. Presented by our broker-dealer affiliate, Charles Schwab &amp; Co., Inc., member SIPC, a subsidiary of The Charles Schwab Corporation,&nbsp;Inside the Mind of a Trader&nbsp;uses a mixture of questions and experiments to explore the mindset of three seasoned traders.Episodes premiere weekly starting Tuesday, September 3, 2024.

Inside the Mind of a Trader

Instead of sitting on the sidelines, take control of your financial future by watching Your First Trade. Host Ben Watson, Sr. Manager, Education Coach&nbsp;takes you on an educational journey where you can discover fundamental trading concepts and how to navigate the thinkorswim platform from Charles Schwab &amp; Co., Inc, member FINRA/SIPC, a subsidiary of The Charles Schwab Corporation. Your First Trade program content is presented by Charles Schwab &amp; Co., Inc. a broker/dealer, for educational purposes only.

Your First Trade

     

Welcome to Gamma On! Hosted by Oliver Renick, Gamma On will explore topics and ideas within the trading world that weave in gamma exposure, mathematics, retail trading trends and the interplay with market-makers. Each episode, Oliver will be joined by industry veterans to provide perspective on understanding these markets.&nbsp;

Gamma On

The Wrap is a nightly recap show, delivering the day’s top market headlines and most insightful interviews from Schwab Network's daily market coverage. Airing daily at 7pm ET, it highlights key takeaways from the trading session, expert analysis, and actionable ideas from the network’s best conversations—giving investors a concise, informative look at what moved the markets and what to watch next.

The Wrap

Daily insights for every investor

Schwab Network's Newsletters

Merck (MRK) rallies after FDA drug approval. Kevin Green discusses this as Merck receives FDA approval for drug Winrevair to treat pulmonary arterial hypertension. Green also goes over how Moderna (MRNA) is trading higher after a $750M investment in flu research. Tune in to find out more about the stock market today.

MRK Rallies on Drug Approval & MRNA Researches Flu

Expert commentary about top moving stocks, sectors, and commodities, along with CEO and analyst interviews.